Chempartner Pharmatech Set to Add Two Major Shareholders to Roster

MT Newswires Live

2024/09/12

Chempartner Pharmatech (SHE:300149) said Liang Yufeng and Yu Xianwen are set to become major shareholders in the pharmaceutical company after Hangzhou Ciyangliangjia Investment Management Partnership transfers its holdings in the company.

Ciyangliangjia Investment Management Partnership holds 51,185,660 shares of the company, or a 10.24% stake, according to a Thursday filing with the Shenzhen bourse.

Following the share transfer, Liang will hold a 5.24% stake and Yu will hold a 5.00% stake in Chempartner Pharmatech.

Price (RMB): Â¥4.64, Change: Â¥-0.020, Percent Change: -0.43%

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2466228141"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2466228141\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2466228141?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-12 16:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2466228141","market":"fut","top_or_hot":-1,"title":"Chempartner Pharmatech Set to Add Two Major Shareholders to Roster","media":"MT Newswires Live","content":"<html><body><p>Chempartner Pharmatech Set to Add Two Major Shareholders to Roster</p><p> Chempartner Pharmatech (SHE:300149) said Liang Yufeng and Yu Xianwen are set to become major shareholders in the pharmaceutical company after Hangzhou Ciyangliangjia Investment Management Partnership transfers its holdings in the company.</p><p>Ciyangliangjia Investment Management Partnership holds 51,185,660 shares of the company, or a 10.24% stake, according to a Thursday filing with the Shenzhen bourse.</p><p>Following the share transfer, Liang will hold a 5.24% stake and Yu will hold a 5.00% stake in Chempartner Pharmatech.</p><p>Price (RMB): Â¥4.64, Change: Â¥-0.020, Percent Change: -0.43%</p></body></html>","source":"mtnewswires_live","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chempartner Pharmatech Set to Add Two Major Shareholders to Roster</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChempartner Pharmatech Set to Add Two Major Shareholders to Roster\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">MT Newswires Live</strong><span class=\"h-time small\">2024-09-12 16:43</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><p>Chempartner Pharmatech Set to Add Two Major Shareholders to Roster</p><p> Chempartner Pharmatech (SHE:300149) said Liang Yufeng and Yu Xianwen are set to become major shareholders in the pharmaceutical company after Hangzhou Ciyangliangjia Investment Management Partnership transfers its holdings in the company.</p><p>Ciyangliangjia Investment Management Partnership holds 51,185,660 shares of the company, or a 10.24% stake, according to a Thursday filing with the Shenzhen bourse.</p><p>Following the share transfer, Liang will hold a 5.24% stake and Yu will hold a 5.00% stake in Chempartner Pharmatech.</p><p>Price (RMB): Â¥4.64, Change: Â¥-0.020, Percent Change: -0.43%</p></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://www.mtnewswires.com/\">MT Newswires Live</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0216","symbol_name":"研究試驗","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2466228141","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2466228141","pubTimestamp":1726130580,"columns":[],"sourceInfo":{"source_id":"mtnewswires_live","name":"MT Newswires Live"},"weMediaInfo":null,"summary":"Chempartner Pharmatech Set to Add Two Major Shareholders to Roster Chempartner Pharmatech (SHE:30014","collect":0,"end_time":0,"defaultTopTitle":"mtnewswires.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"300149":"睿智医药","BK0216":"研究试验","SHE":"SPDR MSCI USA Gender Diversity ETF","BK0077":"质押式回购"},"translate_title":"Chempartner Pharmatech将在名册中增加两名主要股东","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300149":1,"SHE":1},"content_text":"Chempartner Pharmatech Set to Add Two Major Shareholders to Roster Chempartner Pharmatech (SHE:300149) said Liang Yufeng and Yu Xianwen are set to become major shareholders in the pharmaceutical company after Hangzhou Ciyangliangjia Investment Management Partnership transfers its holdings in the company.Ciyangliangjia Investment Management Partnership holds 51,185,660 shares of the company, or a 10.24% stake, according to a Thursday filing with the Shenzhen bourse.Following the share transfer, Liang will hold a 5.24% stake and Yu will hold a 5.00% stake in Chempartner Pharmatech.Price (RMB): Â¥4.64, Change: Â¥-0.020, Percent Change: -0.43%","kind":"live","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}